Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 22Gastrointestinal 16Genitourinary 12Other 6Head & Neck 5Thoracic 4Plasma cell 4Lymphoid 4CNS 4Other hematologic neoplasm 3Gynecologic 3Sarcoma 2Endocrine 2Tumor-Agnostic 1Other solid neoplasm 1Myeloid 1Dermatologic 1

Conditions

Multiple Myeloma 3Smoldering Multiple Myeloma 1Neoplasms, Plasma Cell 1Lymphoma 1Leukemia 1

Interventions

Cyclophosphamide 20fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 13Dexamethasone 13Cyclosporine 12Whole-Body Irradiation 11fludarabine 10Exercise 10Antilymphocyte Serum 10Melphalan 9Busulfan 9Blood Specimen Collection 9Mycophenolic Acid 8Therapeutics 7Filgrastim 7Bortezomib 7Standard of Care 6Radiotherapy 6Behavior Therapy 6Acupuncture Therapy 6pomalidomide 5Specimen Handling 5Palliative Care 5Methotrexate 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Educational Status 5daratumumab 4Surveys and Questionnaires 4Stem Cell Transplantation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Resistance Training × Plasma cell × Clear all
NCT05763563 2026-03-31

Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
20 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Neoplasms, Plasma Cell

NCT07045727 2026-03-30

Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Older Patients Undergoing CAR-T Therapy for Relapsed or Refractory Multiple Myeloma

Mayo Clinic

Phase NA Recruiting
20 enrolled
Plasma cell

Multiple Myeloma

NCT05312255 2025-12-01

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Roswell Park Cancer Institute

Phase NA Recruiting
175 enrolled
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

NCT03793907 2023-04-10

Strength Training in Improving Pain and Quality of Life in Patients With Multiple Myeloma

Roswell Park Cancer Institute

Phase NA Completed
65 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡